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by Ernest E. McConnell*
There are several basic principles that apply to the clinicopathologic syndrome produced by polychlo-
rinated biphenyls (PCBs). They are as follows: The degree of halogenation and position of the halogen
atoms determine the potency of PCB, PBB, CDD, CDF and CN; in a given species of animals, the
clinicopathologic syndrome induced by PCB is comparable to that induced by polybrominated biphenyls
(PBB), chlorinated dibenzo-p-dioxins (CDD), chlorinated dibenzofurans (CDF), and chlorinated na-
phthalenes (CN) when an equitoxic dose is achieved; The clinicopathologic syndrome is different in each
species of animals; Different species of animals vary in their susceptibility to intoxication; intoxication
is more readily effected in young animals that in adults; at lethal doses the time between exposure and
death is prolonged (>2 weeks).
Relative Potency of PCBs, CDDs,
CDFs and CNs
It is sometimes difficult to establish which ofthe sub-
ject compounds is the most toxic because, with the ex-
ception of the laboratory environment, most "natural"
exposures are to mixtures of several isomers. In addi-
tion, because of chemical processes used in the manu-
facture ofthese chemicals or ofchemicals in which they
are found as contaminants, more than one class of com-
pound may be involved in a "natural exposure." For
example, it has been shown that the PCBs involved in
"Yusho Disease" were contaminated with CDFs (1) and
PBBs were contaminated with brominated naphthal-
enes (2). Similarly, phenoxy herbicides have been con-
taminated with CDFs as well as CDDs.
To establish clearly the relative toxicity ofeach class
ofcompound would require the study ofthe most toxic
isomer of each class in the same animal species using
the same experimental conditions. This has been done
in vivo (3,4) and in vitro (5,6). The results of these
investigations show a relative ranking oftoxicity as fol-
lows: CDD (most toxic) > CDF >> PCB > CN. These
authors have also demonstrated that a brominated iso-
mer is somewhat more toxic than its chlorinated coun-
terpart. To further add to the complexity ofthis subject
it appears that the various isomers and/or classes may
act in an additive or synergistic manner to each other
(7).
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These findings suggest that itis inappropriate in most
"natural exposures" to attemptto equate the toxic man-
ifestations of the exposure to a single isomer or con-
gener or chemical class unless it has been clearly shown
that the exposure was restricted to that isomer or class
of compound.
Species Sensitivity
There is a considerable difference in the sensitivity of
various speciesofanimalstothesecompounds. However,
in most cases, if a given species is more sensitive than
another to a given class of compound, i.e., PCB, this
species ofanimal will also be more sensitive to the other
classes, i.e., CDDs, CDFs, etc. It has also been
observed that in most instances in regard to the dose of
a given isomer or class of chemical, young animals are
more sensitive than adults and females more sensitive
than males.
While there are a limited number of studies where
the protocols are comparable, the general impression is
that chickens (and possibly other avian species) and
guinea pigs are the most sensitive species ofanimals to
intoxication with these classes ofchemicals (Table 1). In
contrast, hamsters and amphibians appear to be fairly
resistant to the toxic effects, at least to TCDD.
Clinical Signs
The clinical signs of intoxication in animals from
exposure to these classes ofcompounds can be divided
into acute and chronic. At acutely lethal doses the main
clinical sign in most species of animals is a progressiveE. E. McCONNELL
Table 1. Lethal dose (LD50) of 2,3,7,8-TCDD in various animal species.
Observation LD50,
Animal/strain Sex Route period Rg/kg Comments Reference
Guinea pig, Hartley Strain M Gavage 8 weeks 0.6 Time to death 5-34 days (31)
Rats/Sherman M Gavage 8 weeks 22 Time to death 9-27 days (31)
Rats/Sherman F Gavage 8 weeks 45 Time to death 14-43 days (31)
Monkey/rhesus F Gavage 10 weeks <70 Time to death >35 days (3)
Mice/C57B1 M Gavage 60 days 114 Time to death 15-20 days (32)
M Gavage 30 days 284 Time to death 22-25 days (3)
Rabbits/NZ M Gavage 8 weeks 115 Time to death 6-39 days (31)
Hamster M Gavage 55 days 5051 Time to death 26-43 days (33)
loss ofbody weight followed by weakness, debilitation,
and finally death. This is accompained by decreased
food and water intake which accounts for some (8) but
not all of the weight loss (3). These may be the only
signs observed inrats, mice, guinea pigs, rabbits, mink,
and poultry after oral administration. However, skin
lesions have been reported in hairless mice (9), and
acnelike lesions have been described in the ears of
rabbits after local application (10). At times, poultry
may show a terminal increase in body weight due to
accumulation of body fluids (subcutaneous edema,
ascites, hydrothorax and hydropericardium) (11). It is
noteworthy that the time to death in most species is
from several days to weeks even at super lethal
exposures (12).
It is difficult to describe acute signs of toxicity in
non-human primates because they do not die "acutely.'
The time to death is from one to three months even at
doses several timesthe LD50. Inaddition tobodyweight
loss, the clinical syndrome in monkeys (13) and cattle
(14) is characterized by skin and eyelid lesions and
abnormal finger or toe nails or hooves. The lesions in
monkeys are follicular dermatitis (acne) of the face,
neck, and forearms, enlarged tortuous Meibomian
glands in the eyelid and overgrowth and loss ofnails of
the hands and feet. Alopecia may be present, particu-
larly in the areas of the body showing dermatitis. The
skin ofcattle is thickened and dry, particularly over the
neck, shoulders and back. The hooves of intoxicated
animals may be overgrown with associated lameness.
Signs ofpoorfertility and fetalwastage are hallmarks
ofthe disease syndrome in chronic sublethal exposures.
These may be the main clinical features in "natural"
exposures, particularly in monkeys (15), mink (16) and
cattle (17). The reproductive problems appear to be
primarily attributable to the female in these species.
This may be related to the fact that in these species of
animals, females are more sensitive than males to
intoxication of these classes of chemicals. Also, young
animals are more sensitive than adults (12).
Organ Weights
In those studies where organ weights have been
measured, there are two organs that show a weight
effect in most species ofanimals (12). Thethymus shows
a dramatic decrease in weight (actual and relative to
bodyweight), often only25% ofnormal. In contrast, the
liver is usually increased in weight. A decrease in the
weight ofthe gonads has been reported but this may be
a reflection ofdebilitation rather than a direct effect. A
similar explanation may appropriate for the mild
increase in the weight ofthe adrenal gland since it has
been observed at only doses approaching the LD50.
Hematology
Hematological changes appear to be directly related
to lesions in the bone marrow (atrophy), which occur in
all species of animals studied at high (lethal) exposure
levels. In acute studies (<30 days), thrombocytopenia
(18) and lymphopenia have been reported in several
species of laboratory animals. Increased erythrocyte
counts have been reported in acute studies but this may
be related to terminal dehydration which is a consistant
finding in lethally exposed animals.
In chronic studies, the most consistent hematologic
finding is a mild to moderate degree of anemia (12,19).
The white blood cell picture is more complex after long
term exposure. Some studies show decreases in specific
types of leukocytes while other studies show a leuko-
cytosis. Themostplausibleexplanationforthisdisparity
of results is the presence of secondary infections. The
confoundingissue ofsecondary disease has most clearly
been documented in environmental (outside the labora-
tory) exposures, such as the PBB incident in Michigan
(17) and in various PCB/CDF exposures in primate
facilities (15).
Clinical Chemistry
The study ofblood serum changes is one ofthe more
complex features ofintoxication from these compounds.
The reason for this is that the changes in the serum
components reflect lesions in all parts ofthe body. Since
the spectrum of anatomic pathology varies between
species, it is not surprising that serum chemistry
findings also vary since they reflect those lesions. As an
example, increases in serumglutamic-oxaloacetic (GOT)
and glutamic-pyruvate (GPT) transaminases and lactic
dehydrogenase (LDH) were reported in TCDD exposed
rats (18) but not in guinea pigs equally intoxicated (3).
This is readily explained by the fact that rats show a
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Table 2. Summary of lesions in various species of animals.
Lesion severitya
Gall Urinary
Species Thymus Liver bladder Stomach tract Skin
Guinea pig + 3 - + 3
Mouse + 3 + 2 - - b
Rat + 3 + 2 NA + 1
Hamster + 3 + 1 + 2 - + 2 + 1
Chicken + 3 + 3 - + 1
Rabbit + 3 + 3 + 3c
Monkey + 3 + 1 + 3 + 3 + 2 + 3
Cattle + 2 + 1 + 2 - + 2 + 1
aSeverity: ± = minimal; + 1 = mild; + 2 = moderate; + 3=
marked; NA = not applicable.
bPresent in some strains but not others. cP1esent in ear after local application.
significant amount ofliver pathology while it is minimal
in guinea pigs.
Changes in serum lipid have received considerable
attention in studies of these compounds. Rats exposed
to TCDD exhibit hyperlipidemia because ofincreases in
cholesterol and high density lipoproteins (HDL). No
change was observed in low-density lipoproteins (LDL)
or triglycerides (20). In contrast, similarly intoxicated
guinea pigs show an increase in triglycerides and LDL
as well as other lipids.
Decreases in total serum protein, due primarily to a
reduction in the albumin fraction have been reported in
severely intoxicated guinea pigs and mice (3). Changes
have also been reported in specific globulin fractions. It
is interesting that mice exposed to a low level ofTCDD
had increased serum globulins, but decreased levels at a
higher dose (21). These abnormalities have been related
to lesions of the liver and immune system. Functional
abnormalities of the immune system have also been
described but are reported in a separate paper in these
proceedings.
Anatomic Pathology
The macroscopic and microscopic changes induced by
theseclasses ofchemicals havebeenreviewedpreviously
(12). There are two general concepts regarding the
lesions produced by these chemicals: (1) the pathologic
syndrome is essentially the same within a given animal
species for all of these compounds once a toxic is
achieved; (2) the pathologic syndrome varies in different
species of animals (Table 2).
The organ which is consistently affected in all species
is the thymus (12). Additionally, it usually shows changes
at doses lower than those required to cause lesions in
other organs. The primary lesion is a loss of cortical
lymphocytes. In animals lethally exposed to these com-
pounds only a remnant of the cortex may be present.
This is often accompanied bynecroticdebris inthe med-
ulla. At less toxic doses the thymus may look normal
histopathologically while being one halfnormal size. This
is why organ weights are a necessity in evaluating the
toxicopathology of these chemicals.
The liver varies in its response to these classes of
chemicals. In all avian species studied (22) and in
rabbits (10), severe necrosis and hemorrhage are the
hallmarks of lethal intoxication. In fact, death in these
species has been ascribed to severe liver pathology.
Prominent but lesserdegrees ofpathology are observed
in rats and mice while the liver is only minimally
damaged (anatomically) in guinea pigs, cattle, and
monkeys (12). Intrahepatic bile duct hyperplasia has
been described in rodents and monkeys but is a more
prominent feature in chronically exposed animals.
Marked epithelial hyerplasia of the extrahepatic bile
duct and gall bladder have been described in monkeys
(13) and cattle (23). The height and number ofepithelial
cells is increased but more striking is the papillary
appearance of the mucosa. It is so prominent that
macroscopically the bile duct may be two to three times
its normal diameter. Epithelial erosions, ulcers and
inflammation are often part of the lesion.
Hyperplasia ofthe epitheliumliningtheurinary tract
has been described in guinea pigs, cattle and monkeys
(12). The lesion extends from the renal pelvis to the
urinarybladder stoppingatthe leveloftheurethra. The
histologic appearance ofthe epithelium appears normal
in all respects except that the number of cell layers is
increased. The parenchyma ofthe kidney does not show
lesions, although an increased severity of chronic
progressive nephropathy (a common disease related to
aging) has been described in rats exposed chronically to
PCBs (24) and PBBs (25).
The stomach of monkeys exposed to these classes of
chemicals exhibits alesionwhichmaybe pathognomonic
and has been referred to as 'simian gastropathy" (26).
In acute lethal exposures, the chief (acid-producing)
cells are replaced by hyperplastic mucous producing
cells. In more chronic exposures, the hyperplasitc
change becomes more pronounced and at times appears
to invade subjacent tissues. Whether this represents
true invasionis questionable, since itisusually admixed
with ulcerative processes and inflammatory changes.
The lesion may be so prominent that macroscopically it
often appears as a fungoidlike mass suggesting neo-
plasia. However, the lesion has never been shown to
metastasize and will regress if exposure to those
chemicals with a relatively short biological half-life
ceases (27). It should be emphasized that some ofthese
compounds (and congeners thereof) have an extremely
long biological half-life and even though "external"
exposure is stopped the host is still effectively being
exposed via the compound stored in its body. A similar
but much less severe lesion has been described in rats
exposed to PBBs (25). The large intestine also shows
hyperplastic changes in monkeys chronically exposed to
these chemicals (28).
The skin and associated structures of monkeys,
rabbits (ears), and certain strains ofmice show charac-
teristics lesions when the animals are exposed to these
classes ofchemicals. Inmonkeys the lesion is character-
ized microscopically by mild epithelial hyperkeratosis
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and severe atrophy ofsebaceous glands and hyperkera-
tosis of their ducts (13). The ducts become occluded
with keratinaceous debris and grossly the lesion mimics
an acnelike lesion. This lesion is commonly observed on
the face, particularly on or near the nose but may be
found on other areas of the body. A similar lesion is
observed in the Meibomian glands of the eyelid and
ceruminous glands ofthe external suditory canal. These
modified sebaceous glands are severely affected and
may be the most sensitive clinical indicators ofintoxica-
tion. Alopecia and dry scaly skin are also features of
exposure in monkeys.
While most strains of mice do not show skin lesions,
certain "hairless" (actually not hairless since remnants
offollicles are present) strains show asimilarskin lesion
to that in monkeys (29). Again, the lesion appears to be
related to atrophic and hyperkeratotic changes in the
sebaceous glands and their ducts. The inner surface of
a rabbits ear also shows acnelike lesions if these com-
pounds are applied directly to the surface. In fact, this
lesion provides a fairly rapid (7-14 days) bioassay for
the detection of these classes of chemicals (30). Cattle
also show a characteristic skin disease when exposed to
these compounds. Historically, one of the earliest en-
vironment intoxications of these classes of chemicals
involved dairy cattle which showed severe hyperkera-
tosis, particularly on the face, neck and over the shoul-
ders. The disease was caused by exposure to CNs in
axle grease which the cattle ingested (14).
Accumulation of fluid in the subcutis, abdominal
cavity, thorax and pericardial sac is a characteristic
feature of intoxication in avian species. The original
recognition of a possible dioxin problem in animals was
a disasterous episode in chickens which was referred to
as chick edema disease (11). Itresulted in the death and
destruction of hundreds of thousands of chickens and
eggs.
Other lesions have been ascribed to intoxication with
these classes of chemicals (120. These include hemor-
rhage ofthe adrenal, atrophy ofthe zona glomerulosa of
the adrenal cortex, germ cell atrophy ofthe testicle and
ovary and amyloidosis. Whether these are primary
effects or merely a reflection of severe cachexia in
severely intoxicated animals or exacerbation of aging
lesions is debatable. These lesions are observed prima-
rily in animals which die or which are killed in a
moribund condition. In addition, similar lesions are
found in animals extremely sick from other causes or in
aged animals.
The carcinogenic potential of these chemicals is
described in other portions of these proceedings.
Discussion
The clinicopathologic syndrome associated with ex-
posure to these classes of chemicals is fairly character-
istic for each species of animals. Unfortunately, in a
diagnostic situation it is impossible to differentiate be-
tween PCBs, CDDs, CDFs, PBBs or CNs. Diagnosis
is also confounded in many instances by the presence
ofsecondary infectious disease(s). Chemical analysis of
tissue samples is required for a definitive etiological
diagnosis. Even then, it is usually impossible to ascribe
the severity ofintoxication to a given level ofthe chem-
ical in various tissues. In most cases, the presence of
the chemical in tissues means only that the animal was
exposed. The presence ofthe characteristic clinicopath-
ologic syndrome is required forapresumptive diagnosis
ofintoxication. For this reason, a careful post mortum
examinationisrequiredwithcollectionofanappropriate
set of tissues.
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